Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

157008

registered interest
date	20/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	E. coli
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will issue guidance to hospitals so that a case of E.coli bacteria triggers the procedures that would be followed if a case of MRSA were discovered.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	215426
answer	answer is ministerial correction date of answer 27/11/2014 answer text <p>The management of individual cases of <em>E.coli</em> bloodstream infections is the responsibility of local infection prevention and control specialists. However, the Department has asked its expert Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infections to consider the options for reducing the number of <em>E.coli</em> infections, which are not always hospital acquired.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 27/11/2014 17:18:51 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	4079 label Biography information for Julian Sturdy

164367

registered interest
date	24/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Driving: Diabetes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions his Department has had with the Driver and Vehicle Licensing Agency about the prescription of oral medications for type 2 diabetes that carry an increased risk of hypoglycaemia.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	215647
answer	answer is ministerial correction date of answer 27/11/2014 answer text <p>Oral medications are widely used to control high blood glucose levels in patients with type 2 diabetes, leading to reductions in long-term complications of diabetes such as heart and kidney disease. The risk of hypoglycaemia associated with these drugs is well-known and is evaluated in detail both at the time of marketing authorisation approval and in the post-marketing period.</p><p> </p><p> </p><p> </p><p>The Patient Information Leaflet provided with all oral diabetes treatments contains advice on the risk of hypoglycaemia while driving. Patients are instructed to take appropriate precautions or to avoid driving completely if affected by hypoglycaemia.</p><p> </p><p> </p><p> </p><p>In addition, the Driver and Vehicle Licensing Agency’s ‘At a glance guide to the current medical standards of fitness to drive’ (May 2014) provides detailed advice to healthcare professionals on the management of patients receiving oral diabetes therapies who wish to drive.</p><p> </p><p> </p><p> </p><p>The Medicines and Healthcare products Regulatory Agency keeps the safety of medicines under continual review and is in regular discussion on relevant issues with the DVLA and the Department for Transport, most recently regarding the development of public communications for the new offence of driving with certain drugs taken above specified limits, which is due to come into force in March 2015. The new offence mainly involves illegal drugs and those with sedative effects and does not include treatments for diabetes.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 27/11/2014 16:53:36 answering member 4020 label Biography information for George Freeman
tabling member	1538 label Biography information for Rosie Cooper

164387

registered interest
date	24/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Diabetes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to improve awareness of hypoglycaemia among patients with type 2 diabetes.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	215645
answer	answer is ministerial correction date of answer 27/11/2014 answer text <p>Whilst there are no specific activities to improve awareness of hypoglycaemia among patients with type 2 diabetes, NHS England would expect services to be delivered taking account of the National Institute for Health and Care Excellence (NICE) guidelines. Patient education forms part of the NICE pathway for management of type 2 diabetes.</p><p> </p><p><strong> </strong></p><p> </p><p>Furthermore, the outcomes of <em>NICE Quality statement 14: Hypoglycaemia</em> are a reduction in the number of people with diabetes requiring medical attention as a result of a hypoglycaemic episode and a reduction in the rate of recurrence of an episode of hypoglycaemia requiring medical attention over 12 months.</p><p> </p><p><strong> </strong></p><p> </p><p><a href="http://www.nice.org.uk/guidance/qs6/chapter/quality-statement-14-hypoglycaemia" target="_blank">http://www.nice.org.uk/guidance/qs6/chapter/quality-statement-14-hypoglycaemia</a></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/11/2014 16:29:22 answering member 3918 label Biography information for Jane Ellison
tabling member	1538 label Biography information for Rosie Cooper

164395

registered interest
date	24/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Dialysis Machines
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what quality and outcome measures NHS England plans to use to ensure maintenance of clinical quality and quality of service in the proposed transition from specialised to clinical commissioning groups commissioning for dialysis.
tabling member constituency	Weaver Vale
tabling member printed	Graham Evans
uin	215753
answer	answer is ministerial correction date of answer 27/11/2014 answer text <p>NHS England has advised that they are in dialogue with key stakeholders about both the opportunities and challenges of transferring responsibility for renal services. The head of the Specialised Services Task Force in NHS England recently met stakeholders from renal service representative groups and heard their concerns directly.</p><p> </p><p> </p><p> </p><p>The Department intends to launch a public consultation by the end of 2014 on the recommendations put forward by the independent clinically-led advisory group (Prescribed Specialised Services Advisory Group) to transfer commissioning responsibility for renal services from NHS England to clinical commissioning groups (CCGs).</p><p> </p><p> </p><p> </p><p>This public consultation will specifically be asking key stakeholders involved in the provision of renal dialysis what NHS England would need to do to ensure a safe transfer of commissioning responsibilities to CCGs. This consultation will also be asking stakeholders specifically whether the current proposed timescales for the transfer of services are feasible.</p><p> </p><p> </p><p> </p><p>A new Task &amp; Finish group is being established by NHS England through the NHS Commissioning Assembly. This group will look specifically at what support CCGs would require to be able to safely and effectively commission services devolved to them.</p><p> </p><p> </p><p> </p><p>NHS England is committed to issuing commissioning guidance for the safe transfer of services from national NHS England responsibility to local CCG responsibility.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 215754 question first answered 27/11/2014 16:35:27 answering member 3918 label Biography information for Jane Ellison
tabling member	4081 label Biography information for Lord Evans of Rainow

164397

registered interest
date	24/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Dialysis Machines
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment NHS England has made of the level of need for specialist renal services to deal with the complications and emergencies associated with dialysis; and how such services will be commissioned from April 2015.
tabling member constituency	Weaver Vale
tabling member printed	Graham Evans
uin	215754
answer	answer is ministerial correction date of answer 27/11/2014 answer text <p>NHS England has advised that they are in dialogue with key stakeholders about both the opportunities and challenges of transferring responsibility for renal services. The head of the Specialised Services Task Force in NHS England recently met stakeholders from renal service representative groups and heard their concerns directly.</p><p> </p><p> </p><p> </p><p>The Department intends to launch a public consultation by the end of 2014 on the recommendations put forward by the independent clinically-led advisory group (Prescribed Specialised Services Advisory Group) to transfer commissioning responsibility for renal services from NHS England to clinical commissioning groups (CCGs).</p><p> </p><p> </p><p> </p><p>This public consultation will specifically be asking key stakeholders involved in the provision of renal dialysis what NHS England would need to do to ensure a safe transfer of commissioning responsibilities to CCGs. This consultation will also be asking stakeholders specifically whether the current proposed timescales for the transfer of services are feasible.</p><p> </p><p> </p><p> </p><p>A new Task &amp; Finish group is being established by NHS England through the NHS Commissioning Assembly. This group will look specifically at what support CCGs would require to be able to safely and effectively commission services devolved to them.</p><p> </p><p> </p><p> </p><p>NHS England is committed to issuing commissioning guidance for the safe transfer of services from national NHS England responsibility to local CCG responsibility.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 215753 question first answered 27/11/2014 16:35:27 answering member 3918 label Biography information for Jane Ellison
tabling member	4081 label Biography information for Lord Evans of Rainow

164371

registered interest
date	24/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Patients: Safety
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the relationship between cost savings to the NHS and improved patient safety; and if he will make a statement.
tabling member constituency	Stockton North
tabling member printed	Alex Cunningham
uin	215712
answer	answer is ministerial correction date of answer 27/11/2014 answer text <p>The Department commissioned Frontier Economics to investigate the costs of unsafe care in the National Health Service. The final report, <em>Exploring the cost of unsafe care</em> <em>in the NHS</em> suggests that the costs of preventable, adverse events is likely to be more than £1 billion per year, but could be up to £2.5 billion annually. The report, which was published on 16 October, is available at:</p><p> </p><p> </p><p> </p><p><a href="http://www.frontier-economics.com/publications/exploring-the-costs-of-unsafe-care-in-the-nhs/" target="_blank">http://www.frontier-economics.com/publications/exploring-the-costs-of-unsafe-care-in-the-nhs/</a></p><p> </p><p> </p><p> </p><p>The Sign up to Safety campaign launched in June is now working with healthcare organisations to make the NHS one of the safest healthcare systems in the world and contribute to the goal to halve avoidable harm and save 6,000 lives over the next three years.</p><p> </p><p> </p><p> </p><p>It is difficult to disaggregate direct cash releasing savings from this evidence which must take into account the upfront costs of investing in safer care.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 27/11/2014 16:45:29 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	4122 label Biography information for Alex Cunningham

164369

registered interest
date	24/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Primary Health Care
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the Care Quality Commission's risk register relating to primary care, when primary care practices were informed of their ratings; when national and local media were informed of the ratings relating to specific practices nationally or in their locality; and what rights primary care practices have to appeal against the theoretical assessments undertaken nationally without those specific practices having been inspected or given the opportunity to review the data on which the risk assessment was made.
tabling member constituency	Sheffield, Brightside and Hillsborough
tabling member printed	Mr David Blunkett
uin	215717
answer	answer is ministerial correction date of answer 27/11/2014 answer text <p>The Care Quality Commission (CQC) is the independent regulator of health and adult social care in England. The CQC has provided the following information.</p><p> </p><p> </p><p> </p><p>The CQC published its first round of Intelligent Monitoring for general practices on 17 November 2014. Intelligent Monitoring analyses a range of indicators (including surveys and official statistics) to create priority bands for inspection. The bandings are then used to help inform where the CQC prioritise its inspections. The CQC will also use the indicators to raise questions about the quality of care; they will not be used on their own to make final judgements about the quality of care.</p><p> </p><p> </p><p> </p><p>The CQC informed all providers of the launch of general practitioner Intelligent Monitoring with an email that was sent out on 14 November 2014 (with no data included). All band 1 GP practices received a separate email on 14 November 2014 informing them that they were in the highest priority band for inspection.</p><p> </p><p> </p><p> </p><p>The CQC engaged with approximately 400 GP practices prior to the launch of GP Intelligent Monitoring, including sharing the data and hosting a series of meetings. A national media release was sent out on the morning of 17 November.</p><p> </p><p> </p><p> </p><p>The CQC will listen and respond to concerns raised by GP practices. The CQC’s formal appeals processes are for the regulatory judgements the CQC makes and Intelligent Monitoring, is not a regulatory judgement. This comparative information is already in the public domain and known to the practice. The CQC publish this information to be open and transparent about what it knows about providers.</p><p> </p><p> </p><p> </p><p>The CQC plans to update this information every three months so that it can continue to respond to issues as they emerge and to share these with providers and the public. The CQC will be undertaking additional testing and engagement to continually improve indicators to inform this work, and will align its definitions of indicators as far as possible with those used by partner bodies such as NHS England and Public Health England.</p><p> </p><p> </p><p> </p><p>Within the next two years, the CQC will have inspected and rated every general practice in England as Outstanding, Good, Requires Improvement, or Inadequate to help people make informed choices about their care and encourage improvement in quality.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 27/11/2014 17:04:42 answering member 1439 label Biography information for Norman Lamb
tabling member	395 label Biography information for Lord Blunkett

164392

registered interest
date	24/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pancreatic Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if his Department will review the Government's funding for pancreatic cancer research following the recommendations of the report, Pancreatic Cancer Research: A roadmap to change, published by the All Party Parliamentary Group on Pancreatic Cancer.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	215640
answer	answer is ministerial correction date of answer 27/11/2014 answer text <p>My hon. Friend the Parliamentary Under-Secretary of State for Public Health (Jane Ellison) has met recently with my hon. Friend the Member for Lancaster and Fleetwood (Eric Ollerenshaw) to discuss pancreatic cancer research and the report by the All Party Parliamentary Group (APPG) on Pancreatic Cancer and will write to the APPG shortly with comments on the report’s recommendations.</p><p> </p><p> </p><p> </p><p>The Department’s National Institute for Health Research (NIHR) welcomes funding applications for research into any aspect of human health including pancreatic cancer. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p> </p><p> </p><p> </p><p>The available funding for all topic areas including pancreatic cancer is subject to future allocation of the Department’s research and development budget. A budget figure for 2015-16 will be set later this year.</p><p> </p><p> </p><p> </p><p>The NIHR is funding a £2 million five-year programme of research to understand the reasons why cancer diagnosis may be delayed, and to consider new designs for testing for cancer. The programme is a partnership between the Universities of Bristol, Cambridge, Bangor, Durham, Oxford, Exeter, the NIHR and Bristol NHS Clinical Commissioning Group. The programme objectives are to design and test new service pathways to cancer diagnosis which are based on sound medical evidence, make efficient use of resources and take full account of patients' views. The programme includes a study of factors influencing patient appraisal of symptoms and associations with cancer diagnosis. Participants in this study have been referred by their general practitioner to hospital for further investigation of symptoms suggestive of pancreatic, lung, or colorectal cancer.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 215620 215621 215641 question first answered 27/11/2014 17:15:52 answering member 4020 label Biography information for George Freeman
tabling member	4056 label Biography information for Nic Dakin

164393

registered interest
date	24/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pancreatic Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has made of the recommendations in the report of the All Party Parliamentary Group on Pancreatic Cancer, Pancreatic Cancer Research: A roadmap to change.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	215641
answer	answer is ministerial correction date of answer 27/11/2014 answer text <p>My hon. Friend the Parliamentary Under-Secretary of State for Public Health (Jane Ellison) has met recently with my hon. Friend the Member for Lancaster and Fleetwood (Eric Ollerenshaw) to discuss pancreatic cancer research and the report by the All Party Parliamentary Group (APPG) on Pancreatic Cancer and will write to the APPG shortly with comments on the report’s recommendations.</p><p> </p><p> </p><p> </p><p>The Department’s National Institute for Health Research (NIHR) welcomes funding applications for research into any aspect of human health including pancreatic cancer. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p> </p><p> </p><p> </p><p>The available funding for all topic areas including pancreatic cancer is subject to future allocation of the Department’s research and development budget. A budget figure for 2015-16 will be set later this year.</p><p> </p><p> </p><p> </p><p>The NIHR is funding a £2 million five-year programme of research to understand the reasons why cancer diagnosis may be delayed, and to consider new designs for testing for cancer. The programme is a partnership between the Universities of Bristol, Cambridge, Bangor, Durham, Oxford, Exeter, the NIHR and Bristol NHS Clinical Commissioning Group. The programme objectives are to design and test new service pathways to cancer diagnosis which are based on sound medical evidence, make efficient use of resources and take full account of patients' views. The programme includes a study of factors influencing patient appraisal of symptoms and associations with cancer diagnosis. Participants in this study have been referred by their general practitioner to hospital for further investigation of symptoms suggestive of pancreatic, lung, or colorectal cancer.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 215620 215621 215640 question first answered 27/11/2014 17:15:53 answering member 4020 label Biography information for George Freeman
tabling member	4056 label Biography information for Nic Dakin

155929

registered interest
date	17/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Breast Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will take steps to ensure that off-patent bisphosphonate drugs are made routinely available for the new indication of preventing breast cancer spreading to the bone.
tabling member constituency	Redcar
tabling member printed	Ian Swales
uin	214720
answer	answer is ministerial correction date of answer 27/11/2014 answer text <p>Research led by the University of Sheffield on the effects of bisphosphonate treatment on recurrence and cause-specific mortality in women with early breast cancer was presented in 2013. We understand that NHS England’s Breast Cancer Clinical Reference Group plans to incorporate this research into guidance it will be publishing in 2015.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 27/11/2014 16:56:11 answering member 4020 label Biography information for George Freeman
tabling member	4045 label Biography information for Ian Swales